Viewing Study NCT00079456


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-05-18 @ 12:18 PM
Study NCT ID: NCT00079456
Status: COMPLETED
Last Update Posted: 2013-10-11
First Post: 2004-03-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Multiple Myeloma View
None Stage I Multiple Myeloma View
None Stage II Multiple Myeloma View
None Stage III Multiple Myeloma View
Keywords: